[HTML][HTML] Imaging techniques in Alzheimer's disease: a review of applications in early diagnosis and longitudinal monitoring
WM van Oostveen, ECM de Lange - International journal of molecular …, 2021 - mdpi.com
Background. Alzheimer's disease (AD) is a progressive neurodegenerative disorder
affecting many individuals worldwide with no effective treatment to date. AD is characterized …
affecting many individuals worldwide with no effective treatment to date. AD is characterized …
A potential role for apoptosis in neurodegeneration and Alzheimer's disease
CW Cotman, AJ Anderson - Molecular neurobiology, 1995 - Springer
Previous studies have shown that β-amyloid (Aβ) peptides are neurotoxic. Recent data
suggest that neurons undergoing Aβ-induced cell death exhibit characteristics that …
suggest that neurons undergoing Aβ-induced cell death exhibit characteristics that …
Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age
KL Leenders, D Perani, AA Lammertsma, JD Heather… - Brain, 1990 - academic.oup.com
Regional cerebral blood flow (CBF), oxygen extraction ratio (OER), oxygen utilization
(CMRO2) and blood volume (CBV) were measured in a group of 34 healthy volunteers (age …
(CMRO2) and blood volume (CBV) were measured in a group of 34 healthy volunteers (age …
[PDF][PDF] A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET
S Minoshima, KA Frey, RA Koeppe… - Journal of Nuclear …, 1995 - Soc Nuclear Med
To improvethe diagnosticperformanceof PET as an aid in
evaluatingpatientssuspectedofhawig@ 4Jzhalmer'sdisease, we devalopeda …
evaluatingpatientssuspectedofhawig@ 4Jzhalmer'sdisease, we devalopeda …
Brain cytochrome oxidase in Alzheimer's disease
SJ Kish, C Bergeron, A Rajput, S Dozic… - Journal of …, 1992 - Wiley Online Library
A recent demonstration of markedly reduced (‐50%) activity of cytochrome oxidase (CO;
complex 4), the terminal enzyme of the mitochondrial enzyme transport chain, in platelets of …
complex 4), the terminal enzyme of the mitochondrial enzyme transport chain, in platelets of …
FDG PET imaging in patients with pathologically verified dementia
JM Hoffman, KA Welsh-Bohmer… - Journal of Nuclear …, 2000 - Soc Nuclear Med
The purpose of this study was to confirm with pathologic verification 2 beliefs related to
Alzheimer's disease (AD):(a) the long-standing impression that bilateral temporo-parietal …
Alzheimer's disease (AD):(a) the long-standing impression that bilateral temporo-parietal …
Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
JP Seab, WJ Jagust, STS Wong… - Magnetic resonance …, 1988 - Wiley Online Library
Nuclear magnetic resonance (NMR) imaging was employed to study 10 patients with
Alzheimer's disease (AD) and seven healthy elderly control subjects. Coronal sections were …
Alzheimer's disease (AD) and seven healthy elderly control subjects. Coronal sections were …
Patterns of motor impairment in normal aging, mild cognitive decline, and early Alzheimer'Disease
A Kluger, JG Gianutsos, J Golomb… - The Journals of …, 1997 - academic.oup.com
In order to determine the relationship between cognitive dysfunction and motor behavior in
older adults, 41 cognitively normal elderly (NL), 25 cases exhibiting mild cognitive …
older adults, 41 cognitively normal elderly (NL), 25 cases exhibiting mild cognitive …
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis
N Scarmeas, E Zarahn, KE Anderson… - Archives of …, 2003 - jamanetwork.com
Background Regional cerebral blood flow (CBF), a good indirect index of cerebral
pathologic changes in Alzheimer disease (AD), is more severely reduced in patients with …
pathologic changes in Alzheimer disease (AD), is more severely reduced in patients with …
Activity of P-glycoprotein, a β-amyloid transporter at the blood–brain barrier, is compromised in patients with mild Alzheimer disease
Studies in animals and postmortem human brain tissue support a role for P-glycoprotein in
clearance of cerebral β-amyloid across the blood–brain barrier (BBB). We tested the …
clearance of cerebral β-amyloid across the blood–brain barrier (BBB). We tested the …